Multibic

Sodium hydrogen carbonate, magnesium chloride hexahydrate, potassium chloride, sodium chloride and calcium, the active ingredients in Multibic, are an electrolyte solution presented as an intravenous solution for haemodialysis use. It helps maintain electrolyte balance and acid‑base stability in patients undergoing renal dialysis.

GNH USA supplies Multibic as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company adheres to stringent quality standards and provides reliable logistics for global healthcare facilities. Clients benefit from consistent product availability, regulatory compliance, and dedicated technical support.

Multibic is used in renal replacement therapy to support electrolyte and acid‑base management during dialysis. - Renal dialysis: helps maintain electrolyte concentrations and buffering capacity throughout the treatment. - Haemodialysis: provides bicarbonate and essential ions to prevent metabolic acidosis during the procedure. - Peri‑dialysis in kidney transplant patients: supports electrolyte homeostasis when intermittent dialysis is required. - Acute kidney injury requiring dialysis: stabilizes serum potassium and calcium levels. - Chronic dialysis patients: assists in long‑term electrolyte balance.

The following adverse reactions have been reported with the use of Multibic during dialysis.

Common Side Effects: - Mild hypotension: transient drop in blood pressure during infusion. - Nausea: occasional feeling of queasiness. - Headache: mild to moderate intensity. - Transient electrolyte shifts: slight changes in serum potassium or calcium that resolve spontaneously. - Flushing or warmth at the infusion site.

Serious or Rare Side Effects: - Severe hyperkalemia: dangerous elevation of serum potassium. - Severe hyponatremia: marked reduction in sodium levels. - Metabolic alkalosis: excessive increase in blood pH. - Anaphylactic reaction: rare but potentially life‑threatening hypersensitivity. - Cardiac arrhythmia: irregular heart rhythm associated with electrolyte imbalance.

When using Multibic, the following precautions should be observed to ensure patient safety. - Assess baseline electrolyte levels: verify serum sodium, potassium, calcium and magnesium before infusion. - Monitor acid‑base status: check arterial blood gases during treatment. - Use caution in patients with cardiac disease: rapid electrolyte changes may affect heart rhythm. - Avoid rapid infusion rates: administer according to recommended flow to prevent hypotension. - Check compatibility with other IV solutions: ensure no precipitation occurs when mixed. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Multibic may interact with other medications or solutions; the interactions are categorized as follows.

Major Interactions (Avoid): - High‑dose potassium supplements: risk of hyperkalemia when combined. - Calcium‑containing IV solutions: may cause calcium overload and precipitation. - Sodium bicarbonate infusion: additive alkalinizing effect leading to metabolic alkalosis.

Moderate Interactions (Monitor Closely): - Loop diuretics: can amplify electrolyte shifts during dialysis. - ACE inhibitors or ARBs: may increase serum potassium levels. - Beta‑blockers: may mask signs of hypotension from infusion.